BioStem Technologies, Inc. (BSEM)
1.12
-0.17
(-13.18%)
USD |
NASDAQ |
Oct 30, 16:00
1.20
+0.08
(+7.14%)
After-Hours: 20:00
BioStem Technologies Market Cap : 19.96M for Oct. 30, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 29, 2026 | 22.99M |
| October 28, 2026 | 26.91M |
| October 27, 2026 | 26.38M |
| October 26, 2026 | 27.45M |
| October 23, 2026 | 27.98M |
| October 22, 2026 | 29.58M |
| October 21, 2026 | 29.94M |
| October 20, 2026 | 29.23M |
| October 19, 2026 | 27.45M |
| October 16, 2026 | 37.25M |
| October 15, 2026 | 36.36M |
| October 14, 2026 | 37.60M |
| October 13, 2026 | 40.10M |
| October 12, 2026 | 43.48M |
| October 09, 2026 | 44.02M |
| October 08, 2026 | 47.05M |
| October 07, 2026 | 42.59M |
| October 06, 2026 | 44.02M |
| October 05, 2026 | 49.10M |
| October 02, 2026 | 48.65M |
| October 01, 2026 | 54.71M |
| September 30, 2026 | 55.07M |
| September 29, 2026 | 68.26M |
| September 28, 2026 | 72.18M |
| September 25, 2026 | 73.78M |
| Date | Value |
|---|---|
| September 24, 2026 | 69.15M |
| September 23, 2026 | 67.72M |
| September 22, 2026 | 70.93M |
| September 21, 2026 | 78.41M |
| September 18, 2026 | 84.47M |
| September 17, 2026 | 77.70M |
| September 16, 2026 | 72.71M |
| September 15, 2026 | 71.46M |
| September 14, 2026 | 75.03M |
| September 11, 2026 | 76.81M |
| September 10, 2026 | 74.40M |
| September 09, 2026 | 75.03M |
| September 08, 2026 | 71.29M |
| September 04, 2026 | 66.12M |
| September 03, 2026 | 64.34M |
| September 02, 2026 | 63.09M |
| September 01, 2026 | 62.38M |
| August 31, 2026 | 65.58M |
| August 28, 2026 | 62.91M |
| August 27, 2026 | 68.61M |
| August 26, 2026 | 65.23M |
| August 25, 2026 | 67.90M |
| August 24, 2026 | 69.86M |
| August 21, 2026 | 63.09M |
| August 20, 2026 | 65.58M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Filana Therapeutics, Inc. | 30.10M |
| CorMedix, Inc. | 442.31M |
| Eloxx Pharmaceuticals, Inc. | 53.60M |
| Breakthrough Chemistry, Inc. | 0.8562M |
| Cardiac Biotech Solutions, Inc. | 5.164M |
Market Cap Related Metrics
| PS Ratio | 0.6009 |
| Price to Book Value | 0.7228 |
| Price | 1.12 |
| Earnings Yield | -149.9% |